InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Coulie Bernard, Chief Executive Officer. Officer active across 1 company, notably Pliant Therapeutics, INC.. Aggregated, 25 filings have been logged. Breakdown: 0 buy · 11 sells. Total volume traded: €3.9m. Activity tracked since 14 May 2021. The latest transaction was filed on 20 January 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations25 total
89,375 shares@ US$1.2818.1% of flowCommon StockSEC:0001746473-26-000009
89,375 shares@ US$1.280.13% mcap18.1% of flowCommon StockSEC:0001746473-26-000009:0
162,500 shares0Common StockSEC:0001746473-25-000009:0
52,419 shares@ US$11.201113.7% of flowCommon StockSEC:0001746473-25-000006:0
38,710 shares@ US$11.569.9% of flowCommon StockSEC:0001746473-24-000123:0
75,625 shares0Common StockSEC:0001746473-24-000113:0
128,150 shares0Common StockSEC:0001746473-24-000012:0
25,721 shares@ US$17.239.8% of flowCommon StockSEC:0001746473-24-000003:0
70,150 shares@ US$18.009126.9% of flowCommon StockSEC:0001209191-23-042823:0
137,500 shares0Common StockSEC:0001209191-23-042654:0
35,339 shares@ US$26.520920.6% of flowCommon StockSEC:0001209191-23-022362:0
68,749 shares0Common StockSEC:0001209191-23-021915:0
15,000 shares@ US$6.222.0% of flowCommon StockSEC:0001140361-23-004735:0
15,000 shares@ US$2.080.7% of flowCommon StockSEC:0001140361-23-003977:0
146,300 shares0Common StockSEC:0001140361-23-003177:0
15,000 shares@ US$2.080.7% of flowCommon StockSEC:0001140361-23-002786:0
15,000 shares@ US$2.080.7% of flowCommon StockSEC:0001140361-23-001119:0
15,000 shares@ US$2.080.7% of flowCommon StockSEC:0001140361-23-000721:0
68,751 shares0Common StockSEC:0001140361-22-046570:0
12,502 shares@ US$2.080.6% of flowCommon StockSEC:0001567619-22-017430:0
15,000 shares@ US$2.080.7% of flowCommon StockSEC:0001567619-22-013993:0
3,757 shares@ US$32.98272.4% of flowCommon StockSEC:0001209191-21-040760
3,757 shares@ US$32.98270.14% mcap18.8% of flowCommon StockSEC:0001209191-21-040760:0
2,997 shares@ US$28.52810.094% mcap13.0% of flowCommon StockSEC:0001209191-21-033310:0
2,997 shares@ US$28.528113.0% of flowCommon StockSEC:0001209191-21-033310
25 of 25 declarations
About Coulie Bernard
Bernard Coulie is the President and CEO of PLIANT THERAPEUTICS, INC. He is responsible for the strategic and operational leadership of the company. Coulie plays a key role in developing new products and expanding the company's activities.
